Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

SND1 Monoclonal antibody

SND1 Monoclonal Antibody for WB, IHC, IF/ICC, IP, ELISA

Cat No. 60265-1-Ig
Clone No. 1A6A4
Publications (13)
Review Product
Download datasheet

Host / Isotype

Mouse / IgG1

Reactivity

human, mouse, rat

Applications

WB, IHC, IF/ICC, IP, CoIP, RIP, ELISA

100 kDa coactivator, 1A6A4, EBNA2 coactivator p100, EC:3.1.31.1, p100

Formulation:  PBS, Azide, Glycerol
PBS, Azide, Glycerol
PBS Only
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for SND1 in ?

Tested Applications

Positive WB detected inHepG2 cells, HeLa cells, Jurkat cells, U2OS cells, HEK-293 cells, HSC-T6 cells, NIH/3T3 cells, A431 cells, LNCaP cells
Positive IP detected inHeLa cells
Positive IHC detected inhuman pancreas tissue, human breast hyperplasia tissue, human breast cancer tissue, human colon cancer tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
Positive IF/ICC detected inHepG2 cells

Recommended dilution

ApplicationDilution
Western Blot (WB)WB : 1:5000-1:50000
Immunoprecipitation (IP)IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
Immunohistochemistry (IHC)IHC : 1:20-1:200
Immunofluorescence (IF)/ICCIF/ICC : 1:20-1:200
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

Product Information

60265-1-Ig targets SND1 in WB, IHC, IF/ICC, IP, CoIP, RIP, ELISA applications and shows reactivity with human, mouse, rat samples.

Tested Reactivity human, mouse, rat
Cited Reactivityhuman, rat
Host / Isotype Mouse / IgG1
Class Monoclonal
Type Antibody
Immunogen

CatNo: Ag1200

Product name: Recombinant human SND1 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 548-911 aa of BC017180

Sequence: TCLITFLLAGIECPRGARNLPGLVQEGEPFSEEATLFTKELVLQREVEVEVESMDKAGNFIGWLHIDGANLSVLLVEHALSKVHFTAERSSYYKSLLSAEEAAKQKKEKVWAHYEEQPVEEVMPVLEEKERSASYKPVFVTEITDDLHFYVQDVETGTQLEKLMENMRNDIASHPPVEGSYAPRRGEFCIAKFVDGEWYRARVEKVESPAKIHVFYIDYGNREVLPSTRLGTLSPAFSTRVLPAQATEYAFAFIQVPQDDDARTDAVDSVVRDIQNTQCLLNVEHLSAGCPHVTLQFADSKGDVGLGLVKEGLVMVEVRKEKQFQKVITEYLNAQESAKSARLNLWRYGDFRADDADEFGYSR

Predict reactive species
Full Name staphylococcal nuclease and tudor domain containing 1
Calculated Molecular Weight 101 kDa
Observed Molecular Weight 101 kDa
GenBank Accession NumberBC017180
Gene Symbol SND1
Gene ID (NCBI) 27044
RRIDAB_2881386
Conjugate Unconjugated
FormLiquid
Purification MethodProtein G purification
UNIPROT IDQ7KZF4
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Staphylococcal nuclease domain-containing 1 (SND1), is a multifunctional nuclease that consists of four staphylococcal nuclease domains and a tudor domain. SND1 acts as a coactivator that facilitates transcriptional activity of STAT5, 6 and c-Myc. SND1 is a comprising part of the RNA-induced silencing complex(RISC), and takes part in the functions of miRNA, regulates transcription through transcriptional coactivation, RNA interference, RNA splicing, and RNA editing. Higher level of SND1 has been found in colon cancer and prostate cancer, can promote HCC angiogenesis in xenograft model through induction of angiogenic factors.

Protocols

Product Specific Protocols
IF protocol for SND1 antibody 60265-1-IgDownload protocol
IHC protocol for SND1 antibody 60265-1-IgDownload protocol
IP protocol for SND1 antibody 60265-1-IgDownload protocol
WB protocol for SND1 antibody 60265-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

What published studies show

The SND1 Monoclonal antibody (Cat# 60265-1-Ig) has 13 citations across journals including Cell, Science Advances, J Exp Clin Cancer Res, J Neuroinflammation, NPJ Breast Cancer, J Med Chem, Biochem Pharmacol, Anal Chim Acta, Neoplasia, J Cell Physiol, Life Sci Alliance, and eLife. Research fields span virology (SARS-CoV-2, KSHV), cancer (prostate, breast, pancreatic, bladder), neuroinflammation, RNA biology (circRNA, m6A), and protein-protein interactions.

SpeciesApplicationTitle
humanWB

Cell

SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9

Authors - Nora Schmidt
humanWB,IF,CoIP

J Exp Clin Cancer Res

Circ_0004087 interaction with SND1 promotes docetaxel resistance in prostate cancer by boosting the mitosis error correction mechanism.

Authors - Liang Chen
humanIF,ELISA

Sci Adv

Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor.

Authors - Yuan Wang
humanIF

Sci Adv

Oncoprotein SND1 hijacks nascent MHC-I heavy chain to ER-associated degradation, leading to impaired CD8+ T cell response in tumor.

Authors - Yuan Wang
ratWB,IF

J Neuroinflammation

Circular RNA METTL9 contributes to neuroinflammation following traumatic brain injury by complexing with astrocytic SND1

Authors - Chunling Huang
humanRIP

NPJ Breast Cancer

PARG inhibition suppresses breast cancer progression and potentiates immunoresponse through MTDH degradation mediated by E3 ligase ITCH-dependent ubiquitination.

Authors - Junnai Wang
Loading...
||
New chat

Able®

正在加载,请稍候...